BE896143A - Imidazoline-3-oxide 1-oxyl-4-carboxamide prodn. - from 4-methyl cpd. by halogenation then oxidn. in presence of ammonia - Google Patents

Imidazoline-3-oxide 1-oxyl-4-carboxamide prodn. - from 4-methyl cpd. by halogenation then oxidn. in presence of ammonia Download PDF

Info

Publication number
BE896143A
BE896143A BE0/210306A BE896143A BE896143A BE 896143 A BE896143 A BE 896143A BE 0/210306 A BE0/210306 A BE 0/210306A BE 896143 A BE896143 A BE 896143A BE 896143 A BE896143 A BE 896143A
Authority
BE
Belgium
Prior art keywords
imidazoline
oxide
oxyl
ammonia
halogenation
Prior art date
Application number
BE0/210306A
Other languages
French (fr)
Inventor
L B Volodarsky
I A Grigoriev
G I Schukin
V V Martin
L A Vishnevetskaya
Original Assignee
Novosib I Organichskoikhimiii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novosib I Organichskoikhimiii filed Critical Novosib I Organichskoikhimiii
Priority to BE0/210306A priority Critical patent/BE896143A/en
Publication of BE896143A publication Critical patent/BE896143A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Prodn. of imidazoline-3-oxide -1-oxyl-4-carboxamide of formula (I) comprises (1) halogenating 1-hydroxy-2,2,4,5,5-pentamethyl 3-imidazoline-3-oxide (II) in an alcohol then (2) treating the 4-dihalomethyl prod. with ammonia in presence of oxidising agent. Pref. the alcohol is (m)ethanol and the oxidising agent is PbO2 or MnO2. (I) is useful in synthesis of spin-labelling reagents. The method requires only 2 stages (4 in the known procedure), does not use toxic diazomethane and the yield of (I) is increased to 70% (contrast 15%).

Description

       

  !!Procédé d'obtention de l'amide d'acide 2, 2,5,5-té tramé thyl-3-imidazoline3-oxyde-l-oxyl-4-carboxylique et amide obtenu par ledit procédé" La présente invention concerne le domaine de la chimie organique et plus précisément un procédé d'obtention de l'amide d'acide 2,2,5,5-tétraméthyl-3-imidazoline-3-oxyde
-1-oxyl-4-carboxylique, qui peut trouver une application comme composé de départ dans la synthèse des réactifs analytiques marqués de spin.

  
L'un des composés indiqués est l'acide hydroxamique marqué de spin constitué par le 3-hydroxy-2,2,5,5-tétraméthyl-4-imidazolidinone-1-oxyle.

  
On connaît un procédé d'obtention de l'amide d'acide 2,2,5,5-tétraméthyl-3-imidazoline-3-oxyde-1-oxyl-4-

  
 <EMI ID=1.1> 

  
méthyl-3-imidazoline-3-oxyde (II), qui subit une bromuration par le brome dans un alcali aqueux. Le 4-tribromométhyl2,2,5,5-tétraméthyl-3-imidazoline-3-oxyde-1-oxyle (III) formé est soumis à l'hydrolyse avec l'alcali aqueux, traité par l'acide chlorhydrique, et on isole l'acide 2,2,5,5tétraméthyl-3-oxyde-1-oxyl-4-carboxylique (IV). En faisant agir le diazométhane sur l'acide (IV) on obtient un ester, le 4-carbométhoxy-2,2,5,5-tétraméthyl-3-imidazoline-3-oxyde1-oxyle (V) qui, lors de l'interaction avec l'ammoniac,

  
 <EMI ID=2.1> 

  
Izvestia AN SSSR, séria khim., 1979, p. 228). 

  

 <EMI ID=3.1> 


  
Un inconvénient du procédé indiqué tient à ce qu'il est réalisé en plusieurs stades : le procédé comprend quatre stades en partant du 1-hydroxy-2,2,4,5,5-pentaméthyl-3-imidazoline-3-oxyde, ce qui conduit à un très bas rendement en produit visé (1), à savoir un rendement non supérieur à 15%.

  
En outre, le procédé indiqué n'a pas trouvé d'application industrielle.

  
On s'est donc proposé, en modifiant les opérations technologiques, de simplifier la technologie du procédé et d'augmenter le rendement en produit visé.

  
La solution consiste en ce que dans le procédé d'obtention de l'amide d'acide 2,2,5,5-tétraméthyl-3-imidazoline-3-oxyde-1-oxyl-4-carboxylique de formule générale

  

 <EMI ID=4.1> 


  
comprenant l'halogénation du 1-hydroxy-2,2,4,5,5-pentaméthyl-3-imidazoline-3-oxyde, suivie du remplacement de l'halogène et de l'isolement du produit visé, suivant l'invention l'halogénation du 1-hydroxy-2,2,4,5,5-pentaméthyl-3-imidazoline-3-oxyde est effectuée par son interaction avec un halogène au sein d'un alcool, avec traitement subséquent du produit obtenu, le 4-dihalogénométhyl-2,2,5,5tétraméthyl-3-imidazoline-3-oxyde-1-oxyle, par l'ammoniac

  
en présence d'un oxydant.

  
Il est préférable d'employer à titre d'alcool le méthanol ou l'éthanol. Comme oxydant on peut utiliser un oxydant quelconque approprié, de préférence le dioxyde de manganèse ou le dioxyde de plomb.

  
Le procédé revendiqué possède plusieurs avantages en comparaison du procédé connu. Le procédé suivant l'invention rend plus simple la procédure technologique, grâce à l'élimination de certains stades (2 stades au lieu de 4). Le stade d'isolement du produit facilement décomposable (dérivé de tribromure) ainsi que l'utilisation du diazométhane toxique sont exclus. Le procédé suivant l'invention permet d'augmenter le rendement en produit visé jusqu'à 70%. Le procédé indiqué peut être réalisé à l'échelle industrielle étant donné la procédure technologique simple du procédé revendiqué.

Le procédé revendiqué est réalisé comme suit.

  
Le 1-hydroxy-2,2,4,5,5-pentaméthyl-3-imidazoline-3oxyde est halogéné au sein d'un alcool. Comme alcool on peut utiliser un alcool quelconque, de préférence le méthanol

  
ou l'éthanol. Le procédé est réalisé à la température ambiante. Le produit formé, le 4-dihalogénométhyl-2,2,5,5tétraméthyl-3-imidazoline-3-oxyde-1-oxyle (VI) est traité par l'ammoniac en présence d'un oxydant à titre duquel on peut employer le dioxyde de manganèse, le dioxyde de plomb, etc. Le procédé est effectué à la température ambiante.

  
Le rendement atteint 70% en poids.

  
Le procédé est réalisé suivant le schéma : 

  

 <EMI ID=5.1> 


  
D'autres avantages et caractéristiques de l'invention seront mieux compris à la lecture de la description qui va suivre de deux exemples de réalisation concrets mais non limitatifs.

Exemple 1

  
A une solution de 1,72 g (0,01 mole) de 1-hydroxy2,2,4,5,5-pentaméthyl-3-imidazoline-3-oxyde dans 20 ml d'éthanol on ajoute sous brassage une solution de 1,8 g
(0,025 mole) de chlore dans 20 ml d'éthanol, on maintient la solution à la température ambiante pendant 12 heures

  
et on refroidit jusqu'à 0[deg.] . Le résidu de 4-dichlorométhyl-

  
 <EMI ID=6.1> 

  
par filtration de la solution. Le rendement est de 2,4 g
(75%). On ajoute sous brassage 2,4 g du produit obtenu à une suspension de 10 g de Pb02 dans 50 ml d'éthanol contenant 8 ml d'une solution aqueuse concentrée d'ammoniac.

  
On brasse le mélange à la température ambiante pendant

  
12 heures, on sépare le résidu par filtration, on évapore le solvant, on dissout le résidu solide dans le chloroforme, on sépare par filtration et on purifie par chromatographie dans une colonne remplie de silicagel, l'éluant étant le chloroforme. On obtient 1,2 g d'amide d'acide 2,2,5,5tétraméthyl-3-imidazoline-1-oxyl-4-carboxylique (60%), F (température de fusion) = 200-202[deg.]C. 

Exemple 2

  
On obtient le produit visé (rendement 70%) comme dans l'exemple 1, à cette exception près qu'on utilise à

  
 <EMI ID=7.1>  

REVENDICATIONS

  
1.- Procédé d'obtention de l'amide d'acide 2,2,5,5-tétraméthyl-3-imidazoline-3-oxyde-1-oxyl-4-carboxylique de formule générale :

  

 <EMI ID=8.1> 


  
du type comprenant une halogénation de 1-hydroxy-2,2,4,5,5pentaméthyl-3-imidazoline-3-oxyde suivie du remplacement

  
de l'halogène et de l'isolement du produit visé, caractérisé en ce qu'on effectue l'halogénation du 1-hydroxy-2,2,4,5,5pentaméthyl-3-imidazoline-3-oxyde par son interaction avec un halogène au sein d'un alcool, après quoi on traite le 4-dihalogénométhyl-2,2,5,5-tétraméthyl-3-imidazoline-3oxyde-1-oxyle par l'ammoniac en présence d'un oxydant.



  !! Process for obtaining the acid amide 2, 2,5,5-tee screened thyl-3-imidazoline3-oxide-l-oxyl-4-carboxylic acid and amide obtained by said process "The present invention relates to organic chemistry and more specifically a process for obtaining the 2,2,5,5-tetramethyl-3-imidazoline-3-oxide acid amide
-1-oxyl-4-carboxylic acid, which can find application as a starting compound in the synthesis of analytical reagents labeled with spin.

  
One of the compounds indicated is the spin-labeled hydroxamic acid constituted by 3-hydroxy-2,2,5,5-tetramethyl-4-imidazolidinone-1-oxyl.

  
There is known a process for obtaining the acid amide 2,2,5,5-tetramethyl-3-imidazoline-3-oxide-1-oxyl-4-

  
 <EMI ID = 1.1>

  
methyl-3-imidazoline-3-oxide (II), which undergoes bromination by bromine in an aqueous alkali. The 4-tribromomethyl2,2,5,5-tetramethyl-3-imidazoline-3-oxide-1-oxyl (III) formed is subjected to hydrolysis with aqueous alkali, treated with hydrochloric acid, and is isolated. 2,2,5,5tetramethyl-3-oxide-1-oxyl-4-carboxylic acid (IV). By making the diazomethane act on the acid (IV), an ester is obtained, 4-carbomethoxy-2,2,5,5-tetramethyl-3-imidazoline-3-oxide1-oxyl (V) which, during the interaction with ammonia,

  
 <EMI ID = 2.1>

  
Izvestia AN SSSR, serial khim., 1979, p. 228).

  

 <EMI ID = 3.1>


  
A disadvantage of the process indicated is that it is carried out in several stages: the process comprises four stages starting from 1-hydroxy-2,2,4,5,5-pentamethyl-3-imidazoline-3-oxide, this which leads to a very low yield of the targeted product (1), namely a yield of not more than 15%.

  
In addition, the process indicated has not found industrial application.

  
It has therefore been proposed, by modifying the technological operations, to simplify the technology of the process and to increase the yield of targeted product.

  
The solution consists in that in the process for obtaining the 2,2,5,5-tetramethyl-3-imidazoline-3-oxide-1-oxyl-4-carboxylic acid amide of general formula

  

 <EMI ID = 4.1>


  
comprising the halogenation of 1-hydroxy-2,2,4,5,5-pentamethyl-3-imidazoline-3-oxide, followed by the replacement of the halogen and the isolation of the targeted product, according to the invention l halogenation of 1-hydroxy-2,2,4,5,5-pentamethyl-3-imidazoline-3-oxide is carried out by its interaction with a halogen in an alcohol, with subsequent treatment of the product obtained, on 4 -dihalomethyl-2,2,5,5tetramethyl-3-imidazoline-3-oxide-1-oxyl, by ammonia

  
in the presence of an oxidant.

  
It is preferable to use methanol or ethanol as alcohol. Any suitable oxidant may be used as the oxidant, preferably manganese dioxide or lead dioxide.

  
The claimed process has several advantages compared to the known process. The process according to the invention simplifies the technological procedure, by eliminating certain stages (2 stages instead of 4). The isolation stage of the easily decomposable product (tribromide derivative) as well as the use of toxic diazomethane are excluded. The process according to the invention makes it possible to increase the yield of the targeted product up to 70%. The process indicated can be carried out on an industrial scale given the simple technological procedure of the process claimed.

The claimed process is carried out as follows.

  
1-hydroxy-2,2,4,5,5-pentamethyl-3-imidazoline-3oxide is halogenated in an alcohol. As the alcohol, any alcohol can be used, preferably methanol.

  
or ethanol. The process is carried out at room temperature. The product formed, 4-dihalomethyl-2,2,5,5tetramethyl-3-imidazoline-3-oxide-1-oxyl (VI) is treated with ammonia in the presence of an oxidant as an agent which can be used. manganese dioxide, lead dioxide, etc. The process is carried out at room temperature.

  
The yield reaches 70% by weight.

  
The process is carried out according to the scheme:

  

 <EMI ID = 5.1>


  
Other advantages and characteristics of the invention will be better understood on reading the description which follows of two concrete but non-limiting examples of embodiment.

Example 1

  
To a solution of 1.72 g (0.01 mole) of 1-hydroxy2,2,4,5,5-pentamethyl-3-imidazoline-3-oxide in 20 ml of ethanol is added under stirring a solution of 1 , 8 g
(0.025 mole) of chlorine in 20 ml of ethanol, the solution is kept at room temperature for 12 hours

  
and cooled to 0 [deg.]. The residue of 4-dichloromethyl-

  
 <EMI ID = 6.1>

  
by filtration of the solution. The yield is 2.4 g
(75%). 2.4 g of the product obtained are added with stirring to a suspension of 10 g of PbO2 in 50 ml of ethanol containing 8 ml of a concentrated aqueous ammonia solution.

  
The mixture is stirred at room temperature for

  
12 hours, the residue is filtered off, the solvent is evaporated off, the solid residue is dissolved in chloroform, it is filtered off and it is purified by chromatography in a column filled with silica gel, the eluent being chloroform. 1.2 g of 2,2,5,5tetramethyl-3-imidazoline-1-oxyl-4-carboxylic acid amide (60%) are obtained, F (melting temperature) = 200-202 [deg.] vs.

Example 2

  
The target product is obtained (70% yield) as in Example 1, with the exception that it is used at

  
 <EMI ID = 7.1>

CLAIMS

  
1.- Process for obtaining the 2,2,5,5-tetramethyl-3-imidazoline-3-oxide-1-oxyl-4-carboxylic acid amide of general formula:

  

 <EMI ID = 8.1>


  
of the type comprising a halogenation of 1-hydroxy-2,2,4,5,5pentamethyl-3-imidazoline-3-oxide followed by replacement

  
halogen and the isolation of the targeted product, characterized in that the halogenation of 1-hydroxy-2,2,4,5,5pentamethyl-3-imidazoline-3-oxide is carried out by its interaction with a halogen in an alcohol, after which 4-dihalomethyl-2,2,5,5-tetramethyl-3-imidazoline-3oxide-1-oxyl is treated with ammonia in the presence of an oxidant.


    

Claims (1)

2.- Procédé suivant la revendication 1, caractérisé en ce qu'on utilise comme alcool le méthanol ou l'éthanol. 2.- Method according to claim 1, characterized in that methanol or ethanol is used as alcohol. 3.- Procédé suivant l'une des revendications 1 et 2, caractérisé en ce qu'on utilise à titre d'oxydant le dioxyde de plomb ou le dioxyde de manganèse. 3.- Method according to one of claims 1 and 2, characterized in that one uses as oxidant lead dioxide or manganese dioxide. 4.- Amide d'acide 2,2,5,5-tétraméthyl-3-imidazoline 4.- 2,2,5,5-Tetramethyl-3-imidazoline acid amide -3-oxyde-1-oxyl-4-carboxylique, caractérisé en ce qu'il est obtenu par le procédé faisant l'objet de l'une des revendications 1, 2 et 3. -3-oxide-1-oxyl-4-carboxylic, characterized in that it is obtained by the process which is the subject of one of claims 1, 2 and 3.
BE0/210306A 1983-03-14 1983-03-14 Imidazoline-3-oxide 1-oxyl-4-carboxamide prodn. - from 4-methyl cpd. by halogenation then oxidn. in presence of ammonia BE896143A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BE0/210306A BE896143A (en) 1983-03-14 1983-03-14 Imidazoline-3-oxide 1-oxyl-4-carboxamide prodn. - from 4-methyl cpd. by halogenation then oxidn. in presence of ammonia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE0/210306A BE896143A (en) 1983-03-14 1983-03-14 Imidazoline-3-oxide 1-oxyl-4-carboxamide prodn. - from 4-methyl cpd. by halogenation then oxidn. in presence of ammonia

Publications (1)

Publication Number Publication Date
BE896143A true BE896143A (en) 1983-09-14

Family

ID=3862068

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/210306A BE896143A (en) 1983-03-14 1983-03-14 Imidazoline-3-oxide 1-oxyl-4-carboxamide prodn. - from 4-methyl cpd. by halogenation then oxidn. in presence of ammonia

Country Status (1)

Country Link
BE (1) BE896143A (en)

Similar Documents

Publication Publication Date Title
CN1926102B (en) Process for preparing N-protected 4-ketoproline derivatives
CA1183132A (en) Heparin esters used for the preparation of drugs and preparation process
JP2997979B2 (en) Method for producing 5-aminolevulinic acid
EP1907396B1 (en) Method for preparing 4 -amino-4&#39;-demethyl-4-desoxypodophyllotoxin
EP0566468A2 (en) Process for the preparation of a biphenyl derivative
BE896143A (en) Imidazoline-3-oxide 1-oxyl-4-carboxamide prodn. - from 4-methyl cpd. by halogenation then oxidn. in presence of ammonia
EP0326470B1 (en) Method of producing alkyl pyruvates
EP0573361B1 (en) Process for the preparation of esters of 2,2-dimethyl-3-((Z)-2-(alkoxycarbonyl)ethenyl)cyclopropanecarboxylic acid and intermediates
JPH0141152B2 (en)
EP0153212B1 (en) 4,4-dimethyl tetrahydro-2h-pyran-2-on derivatives, process for their preparation and their use for the preparation of cyclopropanic derivatives
EP0117861B1 (en) Process for the preparation of vincristine
CA2017310A1 (en) Process for preparing 1-chloro-3-(2-methyl-5-nitroimidazol-1-yl)propan-2-o1
FR2460951A1 (en) PROCESS FOR THE PREPARATION OF 15-HYDROXYIMINO-E-HOMOEBURNANE DERIVATIVES AND COMPOUNDS OBTAINED THEREBY
EP1578714B1 (en) Novel chiral compounds derived from hexanoic acid esters, method and intermediate chemicals for the preparation and use thereof for synthesis of 2-(bromomethyl)2-ethyl hexanoic chiral acid
EP0277052B1 (en) 4,4-dimethyltetrahydropyr-2-one derivatives, processes for their preparation and their use in the synthesis of pyretrin products
EP0541446B1 (en) Procedure for preparing 1R, cis 2,2-dimethyl-3-formyl cyclopropane-1-carboxylic acid lactone, and halogenated intermediates
BE896094A (en) Alkyl:halogenated derivs. of imidazoline-oxide prepn. - by direct halogenation of alkyl-imidazoline-oxide, used e.g. as stabiliser, antioxidant or tracer
JPS6140669B2 (en)
EP0194221B1 (en) Process for the preparation of the para-chlorophenol ester of para-chlorophenoxybutyric acid
FR2590254A1 (en) PROCESS FOR OBTAINING ETHYL ESTER FROM APOVINCANIMIC ACID
FR2576021A1 (en) Compounds with anthelmintic activity, method for preparing them and pharmaceutical composition containing them
FR2487836A1 (en) 9- And 11-halo 14-oxo 15-hydroxy 17-alpha-alkyl e-homo eburnane(s) - esp. bromo cpds. are intermediates for halo-vincaminic acid esters and are prepd. by halogenation of corresp. homo-eburnane
FR2609466A1 (en) New 4,4-dimethyltetrahydro-2-pyrone derivatives, process for their preparation and their application to the synthesis of pyrethroid products
BE823745A (en) IMPROVED PROCESS FOR THE PREPARATION OF PENICILLINS SUBSTITUTED IN POSITION 6 BY AN ALCOXY GROUP
FR2653129A1 (en) Process for the preparation of 7-oxocholanates

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: NOVOSIBIRSKY INSTITUT ORGANICHSKOIKHIMIII SIBIRSK

Effective date: 19910331